TATA HEALTH (01255) expects a mid-term loss attributable to shareholders of no more than HKD 1.5 million.

21:30 28/08/2026

TATA Health (01255) announced that the board wishes to clarify that after reviewing the latest unaudited consolidated financial statements for the six months ended June 30, 2026, and other currently available information, the company found a minor clerical error in the profit warning announcement. It is expected that the loss attributable to the company's owners during the reporting period will be reduced from approximately HKD 12.399 million to no more than HKD 1.5 million.

TATA HEALTH (01255) issued a statement clarifying that after reviewing the latest unaudited consolidated financial statements for the six months ending June 30, 2026, and other available information published subsequently, the company discovered a minor clerical error in the profit warning announcement. It is expected that the loss attributable to the owners of the company during the reporting period will be reduced from approximately HKD 12.399 million to no more than HKD 1.5 million.

ZHONGLIANG HLDG (02772) announced its interim results, with a loss attributable to the company's shareholders of 3.572 billion yuan, an increase of approximately 3.57 times compared to the same period last year.

LAIFUAL (03952) plans to apply for a credit facility from financial institutions with a total amount of up to 1.5 billion yuan.

FUFENG GROUP (00546) announced its interim results, with a profit attributable to shareholders of 347 million yuan, a year-on-year decrease of 80.66%.

LAIFUAL (03952) plans to apply for a credit facility from financial institutions with a total amount of up to 1.5 billion yuan.

FUFENG GROUP (00546) announced its interim results, with a profit attributable to shareholders of 347 million yuan, a year-on-year decrease of 80.66%.